Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Gold to Hit US$4,000, Driver for Next Leg Up — West Red Lake’s Shane Williams July 18, 2025 Platinum Price Forecast: H1 2025 in Review July 18, 2025 Rob McEwen: Gold to Go “Much Higher,” Mining Stock Mania Not Here Yet July 18, 2025
